price jul usd
hold rate reect view numer structur challeng
could result downsid street organ revenu growth expect
result follow conserv outlook cynosur
growth margin trajectori support thesi
thing like
breast health busi star perform quarter breast
health constant currenc sale growth acceler meaning
prior quarter report strength
intern busi intern compani report
fourth consecut quarter sale growth addit sale
growth busi acceler intervent breast
solut growth also healthi recently-launch
brevera breast biopsi system contribut strength
share repo tuck-in deal commentari signal increas use
capit deploy lever opportunist repurchas
million share quarter also announc acquisit
faxitron bioptic tuck-in acquisit intend augment
intervent breast solut busi expect deal
neutral fy adjust ep accret thereaft lastli
believ manag commentari confer call signal
increas focu opportunist capit deploy tuck-in
thing cautiou
cautiou cynosur growth outlook follow confer
call cautiou cynosur growth trajectori
cynosur busi modestli exceed sale forecast
manag outlook anticip sequenti sale declin
reect season well caution around potenti impact
recently-receiv fda letter concern market practic relat
cynosur monalisa touch product cynosur sale
consequ take conserv tack outlook
take conserv view margin trajectori adjust
gross margin miss forecast basi point driven
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
advers impact relat product geograph mix inde
intern sale lower gross margin rel
busi intern remain outsiz growth driver
place pressur gross margin addit plan increas
fund key growth initi primarili mean compani
like need focu ecienc eort sg line lastli
enact propos china tari would result addit
headwind consequ narrow adjust oper
margin expans forecast fy relat margin
pressur oset contempl manag plan continu
focu drive ecienc also expect draw margin
benet grow sale contribut viral load product
softwar product breast health busi consum
product cynosur busi
rais pt
rais pt new pt reect enterpris valu
use project level debt cash ttm ebitda
ex option roll valuat framework forward month previous
reect ttm ebitda ex option forecast also increas
ev/ebitda multipl reect higher group multipl
forecast ratio
period end expens share share sale growth ex acquir intang cash flowoper cash cash sale
period end asset cash receiv incom tax held expens defer tax current plant intang asset liabil current portion long term current current debt net incom tax long-term liabil stockhold juli
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
disclosur mark asterisk may also requir least one jurisdict addit unit state see
import disclosur requir non-u regul explanatori note
within past year deutsch bank and/or aliat manag co-manag public privat
oer compani receiv fee
deutsch bank and/or aliat make market equiti secur issu compani
deutsch bank and/or aliat receiv compens compani provis
invest bank nancial advisori servic within past year
import disclosur requir non-u regul
